Our results show that ACE prevents TNFα-induced migration of MDA-MB-231 metastatic breast cancer cells and inhibits TNFα-induced CXCR3 and CXCL10 expression through inhibition of the IκB kinase (IKK)-mediated NF-κB pathway. Here, ACE is linked to breast carcinoma.